China National Accord Medicines (SZSE:000028) Pretax Margin %

: 3.10% (As of Mar. 2023)

View and export this data going back to 1993. Start your Free Trial

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. China National Accord Medicines's Pre-Tax Income for the three months ended in Mar. 2023 was ¥578 Mil. China National Accord Medicines's Revenue for the three months ended in Mar. 2023 was ¥18,687 Mil. Therefore, China National Accord Medicines's pretax margin for the quarter that ended in Mar. 2023 was 3.10%.

The historical rank and industry rank for China National Accord Medicines's Pretax Margin % or its related term are showing as below:

SZSE:000028' s Pretax Margin % Range Over the Past 10 Years
Min: 2.89 Med: 3.49 Max: 3.89
Current: 3.35

SZSE:000028's Pretax Margin % is ranked better than
54.02% of 87 companies
in the Medical Distribution industry
Industry Median: 2.89 vs SZSE:000028: 3.35

China National Accord Medicines Pretax Margin % Historical Data

The historical data trend for China National Accord Medicines's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Pretax Margin %

3.89

3.51

3.62

2.89

3.15

China National Accord Medicines Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Pretax Margin %																2.20	3.47	2.89	3.94	3.10

China National Accord Medicines Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

China National Accord Medicines's Pretax Margin for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	2311.07	/	73443.137
	=	3.15 %

China National Accord Medicines's Pretax Margin for the quarter that ended in Mar. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Mar. 2023 )	/	Revenue (Q: Mar. 2023 )
	=	578.487	/	18686.818
	=	3.10 %

China National Accord Medicines (SZSE:000028) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

China National Accord Medicines Pretax Margin % Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Pretax Margin %

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines